Blood Test for MS Activity Gets FDA Breakthrough Designation Blood Test for MS Activity Gets FDA Breakthrough Designation

Roche ' s Elecsys NfL test is intended to be used as an aid in detection of disease activity in adults with relapsing-remitting multiple sclerosis or secondary progressive multiple sclerosis.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news